Would patients with more subtle signs of coagulopathy have benefited from treatment with activated protein C?
Dominique D
DD
Benoit
Pieter O
PO
Depuydt
Jan J
JJ
De Waele
Eric A
EA
Hoste
Kirsten E
KE
Colpaert
Vanessa D
VD
Van Hende
Johan M
JM
Decruyenaere
D018806:APACHE; D001778:Blood Coagulation Disorders / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D001780:Blood Coagulation Tests; D006801:Humans; D009102:Multiple Organ Failure / Q000209:etiology; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000097:blood* / Q000150:complications
D011486:Protein C; D011994:Recombinant Proteins